Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samit Ghosal

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Diabetes & Metabolic Syndrome|May 20, 2020
Impact of complete lockdown on total infection and death rates: A hierarchical cluster analysisSamit Ghosal, Rahul Bhattacharyya, Milan Majumder
Diabetes & Metabolic Syndrome|November 17, 2012
Quantitative vibration perception threshold in assessing diabetic neuropathy: is the cut-off value lower for Indian subjects? [Q-VADIS Study]Samit Ghosal, Jeff Stephens, Aninda Mukherjee
ESC Heart Failure|January 27, 2023
Heterogeneity in cardiovascular death or hospitalization for heart failure benefits with flozins is linked to weightSamit Ghosal, Binayak Sinha, Rik Mukherjee
Diabetes & Metabolic Syndrome|August 7, 2020
"Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors - A survey"Kalyan Kumar Gangopadhyay, Binayak Sinha, Samit Ghosal
Scientific Reports|July 9, 2025
MISHTI study evaluating hepatic fibrosis in type 2 diabetes patients in IndiaDebasis Datta, Krishna G Seshadri, Samit Ghosal
Diabetes & Metabolic Syndrome|January 30, 2016
Insulin glargine versus insulin degludec in patients failing on oral therapy in type 2 diabetes: A retrospective real world comparative data from IndiaSamit Ghosal, Binayak Sinha, Kalyan Kumar Gangopadhyay
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 2, 2014
Is insulin degludec a more effective treatment for patients using high doses of insulin glargine but not attaining euglycemia? Some case reports from IndiaBinayak Sinha, Kalyan Kumar Gangopadhyay, Samit Ghosal
Diabetes & Metabolic Syndrome|April 17, 2020
Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases - March 14th 2020)Samit Ghosal, Sumit Sengupta, Milan Majumder, et al.
Indian Heart Journal|June 15, 2020
Quantitative measure of asymptomatic cardiovascular disease risk in Type 2 diabetes: Evidence from Indian outpatient settingSamit Ghosal, Binayak Sinha, Jignesh Ved, et al.
Diabetes & Metabolic Syndrome|April 17, 2020
Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysisSamit Ghosal, Binayak Sinha, Milan Majumder, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Diabetes & Metabolic Syndrome|May 20, 2020
Impact of complete lockdown on total infection and death rates: A hierarchical cluster analysisSamit Ghosal, Rahul Bhattacharyya, Milan Majumder
Diabetes & Metabolic Syndrome|November 17, 2012
Quantitative vibration perception threshold in assessing diabetic neuropathy: is the cut-off value lower for Indian subjects? [Q-VADIS Study]Samit Ghosal, Jeff Stephens, Aninda Mukherjee
ESC Heart Failure|January 27, 2023
Heterogeneity in cardiovascular death or hospitalization for heart failure benefits with flozins is linked to weightSamit Ghosal, Binayak Sinha, Rik Mukherjee
Diabetes & Metabolic Syndrome|August 7, 2020
"Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors - A survey"Kalyan Kumar Gangopadhyay, Binayak Sinha, Samit Ghosal
Scientific Reports|July 9, 2025
MISHTI study evaluating hepatic fibrosis in type 2 diabetes patients in IndiaDebasis Datta, Krishna G Seshadri, Samit Ghosal
Diabetes & Metabolic Syndrome|January 30, 2016
Insulin glargine versus insulin degludec in patients failing on oral therapy in type 2 diabetes: A retrospective real world comparative data from IndiaSamit Ghosal, Binayak Sinha, Kalyan Kumar Gangopadhyay
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 2, 2014
Is insulin degludec a more effective treatment for patients using high doses of insulin glargine but not attaining euglycemia? Some case reports from IndiaBinayak Sinha, Kalyan Kumar Gangopadhyay, Samit Ghosal
Diabetes & Metabolic Syndrome|April 17, 2020
Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases - March 14th 2020)Samit Ghosal, Sumit Sengupta, Milan Majumder, et al.
Indian Heart Journal|June 15, 2020
Quantitative measure of asymptomatic cardiovascular disease risk in Type 2 diabetes: Evidence from Indian outpatient settingSamit Ghosal, Binayak Sinha, Jignesh Ved, et al.
Diabetes & Metabolic Syndrome|April 17, 2020
Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysisSamit Ghosal, Binayak Sinha, Milan Majumder, et al.
Pageof 6